EXG PulseLinQ Cables (EXGPL)
510(k) clearance · K262816
- Decision
- Cleared (substantially equivalent)
- Decision date
- Received by FDA
- 7 August 2026
- Applicant
- Cb Innovations, LLC
- Generic name
- Cable, Transducer And Electrode, Patient, (Including Connector)
- Product code
- DSA
- Specialty (advisory committee)
- Cardiovascular
- Device class
- 2
- Regulation number
- 870.2900
- Review type
- Traditional
- FDA AI-enabled device list
- Not on the list
- Product type
- None of the seven digital health types
- Digital health
- Not tagged. A software product code, FDA's AI-enabled list or a digital health category sets the tag.
Sources
- FDA record for K262816 (opens in a new tab)
- openFDA device decisions (opens in a new tab) Licence: cc0. Fetched
Data provided by the U.S. Food and Drug Administration (openFDA, CC0). openFDA publishes decisions only. Nothing on this page is investment advice.